Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 10.50
-0.23 (-2.14%)
Jan 28, 2026, 4:00 PM EST
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 111.86M CNY in the quarter ending September 30, 2025, a decrease of -22.65%. This brings the company's revenue in the last twelve months to 480.48M, up 6.98% year-over-year. In the year 2024, Sinotherapeutics had annual revenue of 511.62M with 70.61% growth.
Revenue (ttm)
480.48M
Revenue Growth
+6.98%
P/S Ratio
9.70
Revenue / Employee
1.54M
Employees
312
Market Cap
4.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | 319.16M | 180.30M | 129.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.13B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Tibet Weixinkang Medicine | 1.17B |